Phase Ib study of pembrolizumab and XL888 in patients with advanced colorectal cancer

被引：0
作者：
Alese, O. [1 ]
Gbolahan, O. B. [1 ]
McCook-Veal, A. [1 ]
Coleman, K. [1 ]
Greene, E. [1 ]
Horvat, N. [1 ]
Switchenko, J. [1 ]
Lesinski, G. [1 ]
El-Rayes, B. F. [2 ]
机构：
[1] Emory Univ, Winship Canc Inst, Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Hematooncol Dept, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [31] Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
    Park, H.
    Shapiro, G., I
    Gao, X.
    Mahipal, A.
    Starr, J.
    Furqan, M.
    Singh, P.
    Ahrorov, A.
    Gandhi, L.
    Ghosh, A.
    Hickman, D.
    Gallacher, P. D.
    Wennborg, A.
    Attar, E. C.
    Awad, M. M.
    Das, S.
    Dumbrava, E. E.
    ESMO OPEN, 2022, 7 (05)
  • [32] Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Iyer, Renuka
    Sonti, Sahithi
    Mahalingam, Devalingam
    Mukherjee, Sarbajit
    Chakraborty, Sayan
    Attwood, Kristopher
    George, Anthony
    Maguire, Orla
    Minderman, Hans
    Fountzilas, Christos
    CANCER RESEARCH, 2024, 84 (07)
  • [33] Phase I study of vemurafenib (VEM) and cobimetinib (COB) with heat shock protein 90 (HSP90) inhibitor XL888 in advanced BRAFV600 mutant melanoma.
    Eroglu, Zeynep
    Chen, Ann
    Li, Jiannong
    Markowitz, Joseph
    Brohl, Andrew Scott
    Tetteh, Leticia
    Karpisek, Adam
    Taylor, Hayley
    Messina, Jane
    Sondak, Vernon K.
    Khushalani, Nikhil I.
    Smalley, Keiran
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer
    Harding, James J.
    Zhu, Andrew X.
    Bauer, Todd M.
    Choueiri, Toni K.
    Drilon, Alexander
    Voss, Martin H.
    Fuchs, Charles S.
    Abou-Alfa, Ghassan K.
    Wijayawardana, Sameera R.
    Wang, Xuejing Aimee
    Moser, Brian A.
    Urunuela, Arantxa
    Wacheck, Volker
    Bendell, Johanna C.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5202 - 5211
  • [35] Phase II study of flavopiridol in patients with advanced colorectal cancer
    Aklilu, M
    Kindler, HL
    Donehower, RC
    Mani, S
    Vokes, EE
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1270 - 1273
  • [36] Phase Ib Study of Crizotinib Plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation
    Patel, Sandip Pravin
    Pakkala, Suchita
    Pennell, Nathan A.
    Reckamp, Karen L.
    Lanzalone, Silvana
    Polli, Anna
    Tarazi, Jamal
    Robert-Vizcarrondo, Francisco
    ONCOLOGIST, 2020, 25 (07) : 562 - +
  • [37] Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer
    Gray, Jhanelle E.
    Saltos, Andreas
    Tanvetyanon, Tawee
    Haura, Eric B.
    Creelan, Ben
    Antonia, Scott J.
    Shafique, Michael
    Zheng, Hong
    Dai, Wenjie
    Saller, James J.
    Chen, Zhihua
    Tchekmedyian, Nishan
    Goas, Kristen
    Thapa, Ram
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Beg, Amer A.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6623 - 6632
  • [38] A phase Ib study of BBI608 in combination with FOLFIRI with and without bevacizumab in patients (pts) with advanced colorectal cancer (CRC)
    Hubbard, Joleen Marie
    Jonker, Derek J.
    O'Neil, Bert H.
    Halfdanarson, Thorvardur Ragnar
    Grothey, Axel
    Li, Youzhi
    Borodyansky, Laura
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
    Herting, Cameron J.
    Farren, Matthew R.
    Tong, Yan
    Liu, Ziyue
    O'Neil, Bert
    Bekaii-Saab, Tanios
    Noonan, Anne
    McQuinn, Christopher
    Mace, Thomas A.
    Shaib, Walid
    Wu, Christina
    El-Rayes, Bassel F.
    Shahda, Safi
    Lesinski, Gregory B.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3337 - 3348
  • [40] A PHASE IB TRIAL OF ZIV-AFLIBERCEPT PLUS PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Tyan, Kevin
    Rahma, Osama
    Giobbie-Hurder, Anita
    Brohl, Andrew
    Bedard, Philippe
    Renouf, Daniel
    Sharon, Elad
    Streicher, Howard
    Hathaway, Emma
    Cunningham, Rachel
    Manos, Michael
    Severgnini, Mariano
    Rodig, Scott
    Hodi, F. Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A402 - A404
12345